Avita Medical (RCEL) and Its Peers Head to Head Review

Avita Medical (NASDAQ:RCEL) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its competitors? We will compare Avita Medical to related businesses based on the strength of its valuation, earnings, dividends, profitability, institutional ownership, analyst recommendations and risk.

Earnings & Valuation

This table compares Avita Medical and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Avita Medical	$71.61 million	-$48.59 million	-11.00
Avita Medical Competitors	$1.89 billion	$138.79 million	11.24

Avita Medical’s competitors have higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Avita Medical and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Avita Medical	-56.96%	N/A	-78.53%
Avita Medical Competitors	-278.16%	-150.10%	-21.89%

Analyst Recommendations

This is a summary of current ratings and target prices for Avita Medical and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1	1	5	0	2.57
Avita Medical Competitors	4266	10509	18262	826	2.46

Avita Medical presently has a consensus price target of $12.20, suggesting a potential downside of 22.98%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 17.07%. Given Avita Medical’s competitors higher probable upside, analysts plainly believe Avita Medical has less favorable growth aspects than its competitors.

Volatility and Risk

Avita Medical has a beta of 2.03, indicating that its share price is 103% more volatile than the S&P 500. Comparatively, Avita Medical’s competitors have a beta of 2.57, indicating that their average share price is 157% more volatile than the S&P 500.

Institutional and Insider Ownership

27.7% of Avita Medical shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 2.2% of Avita Medical shares are held by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Avita Medical competitors beat Avita Medical on 9 of the 13 factors compared.

About Avita Medical

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.